Spatial transcriptomics and immunophenotyping uncover chronic inflammation-induced immune adaptations favoring dysplasia development in patients at risk of colitis-associated cancer - Summary - MDSpire

Spatial transcriptomics and immunophenotyping uncover chronic inflammation-induced immune adaptations favoring dysplasia development in patients at risk of colitis-associated cancer

  • By

  • Sofía Frigerio

  • Hina N Khan

  • Mojtaba Amini

  • Bregje Mol

  • Andra Neefjes-Borst

  • Manon E Wildenberg

  • Cyriel Y Ponsioen

  • Geert R D’Haens

  • Yvonne Vercoulen

  • Joep Grootjans

  • October 13, 2025

  • 0 min

Share

Objective:

To determine chronic inflammation-induced immune cell reprogramming, particularly focusing on specific immune cell types, in IBD patients at risk for developing colitis-associated cancer (CAC).

Key Findings:
  • Histologically uninflamed colon from CAC patients showed upregulated metabolism and stress response pathways compared to SCRC patients, indicating a potential link to dysplasia.
  • Increased IL-10 expression was observed in lamina propria IgA+ plasma cells and CD163+ macrophages in CAC, suggesting a shift in immune response.
  • Downregulation of T cell recruitment and effector pathways was noted in CAC, with decreased CD8+ intraepithelial T cells (IELs), which may contribute to reduced immunosurveillance.
  • IBD patients who developed dysplasia had significantly lower levels of CD8+ IELs compared to those who did not, highlighting a potential biomarker for risk assessment.
Interpretation:

Chronic inflammation induces endogenous anti-inflammatory mechanisms that may limit inflammation but also reduce immunosurveillance, thereby promoting dysplasia and the development of CAC in IBD patients, suggesting avenues for targeted therapies.

Limitations:
  • The study focused on a limited number of patients, which may affect the generalizability of the findings.
  • Potential confounding factors related to treatment history, such as specific medications and duration of IBD, were not fully controlled, which could influence results.
Conclusion:

Chronic inflammation leads to immune adaptations that undermine immunosurveillance, potentially facilitating the development of dysplasia and CAC in IBD patients.

Original Source(s)

Related Content